Neurocrine

Neurocrine, Idorsia part ways 2 years after collab's double phase 2 fails
Fierce Biotech
Tue, 10/29/24 - 11:32 am
Idorsia
Neurocrine
clinical trials
NBI-827104
calcium channel blockers
Neurocrine Hit with Back-to-Back Phase II Failures in Neuropsychiatry
BioSpace
Fri, 11/10/23 - 10:14 am
Neurocrine
neuropsychiatric
clinical trials
focal onset seizures
major depressive disorder
NBI-921352
NBI-1065846
Neurocrine's pediatric phase 3 data are missing piece of puzzle for hyperplasia drug submission
Fierce Biotech
Thu, 10/5/23 - 10:12 am
Neurocrine
hyperplasia
clinical trials
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
FDA
Sandoz
Novartis
Gilead Sciences
Pfizer
Neurocrine
Regeneron
Ipsen
Revance Therapeutics
Delcath Systems
Janssen
Galera Therapeutics
Biogen
Roche
Mesoblast
Taiho Oncology
Look out, Teva. Neurocrine's Ingrezza wins Huntington's disease FDA nod to rival Austedo
Fierce Pharma
Wed, 08/23/23 - 09:48 am
Neurocrine
Ingrezza
FDA
Huntington's disease
Teva Pharmaceutical
FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron
BioSpace
Mon, 08/14/23 - 11:29 am
FDA
Ipsen
Revance Therapeutics
Neurocrine
Regeneron
palovarotene
fibrodysplasia ossificans progressiva
Daxxify
cervical dystonia
Ingrezza
chorea
Huntington's disease
pozelimab
CHAPLE disease
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab
Fierce Biotech
Mon, 01/9/23 - 10:34 am
Voyager Therapeutics
Neurocrine
capsids
CNS
Parkinson's Disease
Neurocrine's $50M bet on Idorsia drug flames out in second PhII
Endpoints
Wed, 12/7/22 - 09:58 am
Neurocrine
Idorsia
clinical trials
NBI-827104
epileptic encephalopathy
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
Neuro drugs dumped by AbbVie are now heading to Neurocrine for $100M up front
MedCity News
Tue, 11/23/21 - 09:40 am
AbbVie
Neurocrine
neurological disorders
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Fierce Pharma
Thu, 03/18/21 - 11:01 am
Horizon Therapeutics
Roche
Genentech
AbbVie
Neurocrine
employee satisfaction
A closely watched schizophrenia drug fails key test
BioPharma Dive
Tue, 03/2/21 - 11:54 pm
Neurocrine
schizophrenia
Takeda
clinical trials
luvadaxistat
Neurocrine Terminates Parkinson's Deal with Voyager Following Clinical Hold
BioSpace
Wed, 02/3/21 - 10:57 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
clinical trials
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
BioSpace
Sat, 05/16/20 - 11:49 am
Neurocrine
drug launches
Ongentys
Parkinson's Disease
pandemic
COVID-19
Neurocrine Biosciences Q1 Beats on Earnings, Revenue
Motley Fool
Thu, 05/7/20 - 10:24 pm
Neurocrine
earnings
FDA Approves Neurocrine Biosciences' Parkinson's Drug
Motley Fool
Mon, 04/27/20 - 07:35 pm
Neurocrine
FDA
Ongentys
Parkinson's Disease
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Biopharma Dive
Sat, 04/25/20 - 12:12 am
Neurocrine
Parkinson's Disease
drug launches
COVID-19
pandemic
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
FDA
regulatory
Bristol-Myers Squibb
ozanimod
Esteve
E-58425
Fabre-Kramer
AstraZeneca
Imfinzi
Astellas
Vesicare
AbbVie
Neurocrine
Orlissa
Sanofi
MenQuadfi
opicapone
Acceleron
Reblozyl
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Thu, 12/5/19 - 10:15 am
Biotech Beach
San Diego
California
Amgen
Neurocrine
Acadia Pharmaceuticals
Retrophin
Tocagen
Mirati Therapeutics
AnaptysBio

Pages